Serapha Bio should halt development of its SERP-01 therapy during the Beam lawsuit

FDA approvals, clinical trial design, psychedelic drug policy, compounding pharmacy regulation, and drug scheduling.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Scientific investigation into biological and medical processes to advance understanding of disease, develop treatments, and improve human health outcomes.